Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

被引:98
|
作者
Washington, K
Wright, K
Shyr, Y
Hunter, EB
Olson, S
Raiford, DS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
关键词
nonalcoholic steatohepatitis; fibrosis; steatosis; hepatic stellate cell;
D O I
10.1053/hupa.2000.8440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Factors associated with the development of fibrosis in nonalcoholic steatohepatitis (NASH) are largely unknown, although an association with increased hepatic iron has been suggested. Hepatic stellate cells are the principal collagen-producing cells in many liver diseases and when activated express alpha-smooth muscle actin (alpha-SMA). Hepatic stellate cell activation and association with fibrosis, necroinflammatory activity steatosis, and stainable iron in 60 cases of NASH and 16 cases of steatosis were evaluated. All 76 patients were obese or had other risk factors for NASH. All biopsy specimens were stained for alpha-smooth muscle actin to evaluate the pattern of hepatic stellate cell activation and were evaluated for inflammatory activity (0 to 3), fibrosis (0 to 4), and stainable iron stores (0 to 4). The zonal location of activated stellate cells was recorded, and the degree of activation was graded as high-grade or low-grade based on the percentage of lobular alpha-SMA+ cells. Activated stellate cells were identified in the hepatic lobule in 74 of 76 biopsy specimens and graded as low-grade in 26 and high-grade in 48. Zone 3 was involved in 72 of 74 positive cases, and in 33 cases, the activated stellate cells were preferentially located in zone 3, The degree of stellate cell activation correlated with fibrosis but not with inflammatory activity, severity of steatosis, or stainable iron. In most cases, the degree of stellate cell activation paralleled the degree of hepatic fibrosis, but in 25 cases, the degree of hepatic stellate cell activation was greater than expected, raising the question of whether such patients are at risk for disease progression. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [31] Activation of hepatic stellate cell in Pten null liver injury model
    He, Lina
    Gubbins, James
    Peng, Zhechu
    Medina, Vivian
    Fei, Fan
    Asahina, Kinji
    Wang, Jiaohong
    Kahn, Michael
    Rountree, Carl B.
    Stiles, Bangyan L.
    FIBROGENESIS & TISSUE REPAIR, 2016, 9
  • [32] Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV
    Squillace, Nicola
    Soria, Alessandro
    Bozzi, Giorgio
    Gori, Andrea
    Bandera, Alessandra
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (07) : 643 - 650
  • [33] Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis
    Tan, Philip K.
    Ostertag, Traci
    Rosenthal, Sara B.
    Chilin-Fuentes, Daisy
    Aidnik, Haylee
    Linker, Sara
    Murphy, Keith
    Miner, Jeffrey N.
    Brenner, David A.
    AMERICAN JOURNAL OF PATHOLOGY, 2024, 194 (03) : 353 - 368
  • [34] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Soejima, Yurie
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (19) : 2300 - 2308
  • [35] Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
    Kim, Mina
    Yang, Su-Geun
    Kim, Joon Mi
    Lee, Jin-Woo
    Kim, Young Soo
    Lee, Jung Il
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (03) : 473 - 479
  • [36] Hepatic Innervations and Nonalcoholic Fatty Liver Disease
    Adori, Monika
    Bhat, Sadam
    Gramignoli, Roberto
    Valladolid-Acebes, Ismael
    Bengtsson, Tore
    Uhlen, Mathias
    Adori, Csaba
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 149 - 162
  • [37] Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications
    Boutari, Chrysoula
    Leikos, Petros
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Tziomalos, Konstantinos
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 214 - 218
  • [39] Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research
    Gottlieb, Aline
    Mosthael, Wesal
    Sowa, Jan-Peter
    Canbay, Ali
    DIGESTION, 2019, 100 (02) : 79 - 85
  • [40] Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Beaton, Melanie D.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (06) : 353 - 357